City appoints new director of healthcare innovation
The ¼â½ÐÊÓƵapp’s Professor Jackie Oldham has been appointed by the city in a new role to make ¼â½ÐÊÓƵapp a leading centre for healthcare business and innovation.
Part of the role will be to promote the collective ¼â½ÐÊÓƵapp offering to create a super cluster of global companies, SME’s and start-ups, co-located with world-class universities and NHS facilities, resources and expertise to attract inward investment.
She said: “The vision is to for this city become a globally recognised centre that attracts the best companies, innovators and investors, is a place of discovery and invention and that fast tracks development of new healthcare innovations to improve the lives of citizens in ¼â½ÐÊÓƵapp and beyond.”
Dr Conor Mulrooney is Chief Operating Officer of , a company based at ¼â½ÐÊÓƵapp Science Partnerships which develops treatments for dysphagia – a serious condition where people are unable to swallow in a safe or controlled way after brain injury. He described how he welcomed this initiative as a collective approach to health innovation in ¼â½ÐÊÓƵapp could help address some of the challenges small companies face including: fast track assessments of new technologies coming to market and support in building the necessary health economic value arguments to drive their widespread adoption.
He commented, “¼â½ÐÊÓƵapp has world class healthcare and academic resources with huge potential to support small businesses. The main challenge is to organise access to them in a simple and practical way. This new development is definitely a step in the right direction.”
The new plans for ¼â½ÐÊÓƵapp build on systems already in place in Boston, USA where institutions such as Harvard, MIT and Massachusetts General Hospital have linked successfully with healthcare and businesses to create one of the world’s leading bio-health innovation centres. Links with Boston build on Professor Oldham’s existing role as Director of ¼â½ÐÊÓƵapp: Integrating Medicine and Innovative Technology (MIMIT), the 1st international affiliate of CIMIT in Boston, USA.
Reflecting on her new role, said: “We want the best companies, investors, innovators and entrepreneurs to be attracted to ¼â½ÐÊÓƵapp to work with us and create a health innovation super cluster to develop new innovations at pace and scale. This is an ambitious plan but by working together we can harness our resources to maximum effect.”
Sir Howard Bernstein, chief executive of , said: "¼â½ÐÊÓƵapp is already a hub for medical research, treatment and innovation and where we have existing strengths we are keen to build on them to create something truly globally distinctive.
“We want to make sure Greater ¼â½ÐÊÓƵapp's devolution deal, and in particular arrangements to integrate health and social care with decisions being taken in the area rather than remotely, provide a platform for further growth.
“I'm confident that this new initiative, and Professor Oldham's role in it, will contribute towards these goals."
Notes for editors
Media enquiries to:
Jamie Brown
Media Relations Officer
The ¼â½ÐÊÓƵapp
Tel: 0161 2758383
Email: jamie.brown@manchester.ac.uk